BSW Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

BSW Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$377K	Buy	605 +87	+17%	+$59.2K	0.04%	219
2026 Q1	$400K	Sell	518 -208	-29%	-$159K	0.05%	201
2025 Q4	$560K	Buy	726 +42	+6%	+$28.5K	0.07%	168
2025 Q3	$385K	Buy	+684	New	+$387K	0.05%	211
2016 Q2	–	Sell	-684	Closed	-$247K	–	69
2016 Q1	$247K	Buy	+684	New	+$282K	0.14%	58

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

BSW Wealth Partners's REGN Position: Q2 2026 in Review

BSW Wealth Partners increased its Regeneron Pharmaceuticals (REGN) stake by 17% in Q2 2026, buying an estimated $59.2K and bringing the position to 605 shares worth $377K. The position accounts for 0.04% of the portfolio, ranked #219.

BSW Wealth Partners first reported a position in REGN in Q1 2016 and has held it in 5 quarters since. The position peaked at $560K in Q4 2025. 406 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

BSW Wealth Partners held 605 shares of Regeneron Pharmaceuticals worth $377K as of Q2 2026.
BSW Wealth Partners bought 87 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $59.2K.
Regeneron Pharmaceuticals made up 0.04% of BSW Wealth Partners's portfolio in Q2 2026, its #219 holding.
BSW Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q1 2016 and has held it in 5 quarters since.
BSW Wealth Partners's Regeneron Pharmaceuticals position peaked at $560K in Q4 2025.
406 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on BSW Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.